Abstract
PET/CT has emerged as ‘standard of care’ modality for imaging of lymphomas, with its utility has been established for staging, restaging, response assessment and surveillance. Fluoro-deoxy-glucose (FDG) targets the glucose transporter receptor and thereby localises in proliferating lymphoid tissue. However, as the modality has evolved over last decade, multiple artefacts, variants and pitfalls were identified. We collated the artefacts, variants and pitfalls documented in literature and by personal experience in this chapter.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Shim HK, Lee WW, Park SY, Kim H, Kim SE. Relationship between FDG uptake and expressions of glucose transporter type 1, type 3, and hexokinase-II in Reed-Sternberg cells of Hodgkin lymphoma. Oncol Res. 2009;17(7):331–7.
Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, Coiffier B, Fisher RI, Hagenbeek A, Zucca E, Rosen ST, Stroobants S, Lister TA, Hoppe RT, Dreyling M, Tobinai K, Vose JM, Connors JM, Federico M, Diehl V, International Harmonization Project on Lymphoma. Revised response criteria for malignant lymphoma. J Clin Oncol. 2007;25(5):579–86.
McCarten KM, Nadel HR, Shulkin BL, Cho SY. Imaging for diagnosis, staging and response assessment of Hodgkin lymphoma and non-Hodgkin lymphoma. Pediatr Radiol. 2019;49(11):1545–64.
Wiyaporn K, Tocharoenchai C, Pusuwan P, Ekjeen T, Leaungwutiwong S, Thanyarak S. Factors affecting standardized uptake value (SUV) of positron emission tomography (PET) imaging with l8F-FDG. J Med Assoc Thai. 2010;93(1):108–14.
EsenAkkas B, Gökaslan D, Güner L, IlginKarabacak N. FDG uptake in brown adipose tissue-a brief report on brown fat with FDG uptake mechanisms and quantitative analysis using dual-time-point FDG PET/CT. Rev Esp Med Nucl. 2011;30(1):14–8.
Tamayo P, Martín A, Díaz L, Cabrero M, García R, García-Talavera P, Caballero D. 18F-FDG PET/CT in the clinical management of patients with lymphoma. Rev Esp Med NuclImagen Mol. 2017;36(5):312–21.
Albano D, Laudicella R, Ferro P, Allocca M, Abenavoli E, Buschiazzo A, Castellino A, Chiaravalloti A, Cuccaro A, Cuppari L, Durmo R, Evangelista L, Frantellizzi V, Kovalchuk S, Linguanti F, Santo G, Bauckneht M, Annunziata S, Young Italian Association of Nuclear Medicine. The role of 18F-FDG PET/CT in staging and prognostication of mantle cell lymphoma: an Italian Multicentric Study. Cancers. 2019;11(12):1831.
Adams HJA, Nievelstein RAJ, Kwee TC. Prognostic value of interim and end-of-treatment FDG-PET in follicular lymphoma: a systematic review. Ann Hematol. 2016;95(1):11–8.
Kung BT, Seraj SM, Zadeh MZ, Rojulpote C, Kothekar E, Ayubcha C, Ng KS, Ng KK, Au-Yong TK, Werner TJ, Zhuang H, Hunt SJ, Hess S, Alavi A. An update on the role of 18F-FDG-PET/CT in major infectious and inflammatory diseases. Am J Nucl Med Mol Imaging. 2019;9(6):255–73.
Han EJ, O JH, Jung SE, Park G, Choi BO, Jeon YW, Min GJ, Cho SG. FDG PET/CT findings of castleman disease assessed by histologic subtypes and compared with laboratory findings. Diagnostics. 2020;10(12):998.
von Falck C, Maecker B, Schirg E, Boerner AR, Knapp WH, Klein C, Galanski M. Post transplant lymphoproliferative disease in pediatric solid organ transplant patients: a possible role for [18F]-FDG-PET(/CT) in initial staging and therapy monitoring. Eur J Radiol. 2007;63(3):427–35.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Puranik, A.D., Shah, S. (2021). PET/CT: Normal Variants, Artefacts and Pitfalls in Non-Hodgkin Lymphoma. In: Agrawal, A., Rangarajan, V., Puranik, A.D. (eds) PET/CT in Non-Hodgkin Lymphoma . Clinicians’ Guides to Radionuclide Hybrid Imaging(). Springer, Cham. https://doi.org/10.1007/978-3-030-79007-3_6
Download citation
DOI: https://doi.org/10.1007/978-3-030-79007-3_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-79006-6
Online ISBN: 978-3-030-79007-3
eBook Packages: MedicineMedicine (R0)